vers la météo de la validation par utilisateur
+------------------------------COMP:V-N(In)-----------------------------+ | +---------------------SUBJ:V-N--------------------+ | | +COMP:N-N(o+ +-----OBJ:V-N----+----COMP:N-N(of)---+ +MOD_A+ +-MOD_ATT:N-N+ +MOD_ATT:+ +MOD+ | +MOD_ATT:+ +MOD_ATT+ | | | | | | | | | | | | | In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases basal expression of __SP__ __NODE__ . MOD_ATT:N-N (cell,H295r) MOD_ATT:N-N (deoxycytidine,aza) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,7) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,deoxycytidine) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (expression,basal) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__)
+------------------------------COMP:V-N(In)-----------------------------+ | +---------------------SUBJ:V-N--------------------+ +MOD_ATT:N-+ | +COMP:N-N(o+ +-----OBJ:V-N----+----COMP:N-N(of)---+ | +MOD_A+ +-MOD_ATT:N-N+ +MOD_ATT:+ +MOD+ | +MOD_ATT:+ +MOD_ATT+ | | | | | | | | | | | | | | In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases basal expression of __SP__ __NODE__ . MOD_ATT:N-N (cell,NCI) MOD_ATT:N-N (cell,H295r) MOD_ATT:N-N (deoxycytidine,aza) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,day) MOD_ATT:N-ADJ (day,7) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,deoxycytidine) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (expression,basal) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__)
+------------------------------COMP:V-N(In)-----------------------------+ | +---------------------SUBJ:V-N--------------------+ | | +-----------OBJ:V-N----------+ +-----OBJ:V-N----+----COMP:N-N(of)---+ +MOD_A+ +-MOD_ATT:N-N+ | +MOD_ATT:+COMP:N+ | | +MOD_ATT:+ +MOD_ATT+ | | | | | | | | | | | | | | In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases basal expression of __SP__ __NODE__ . MOD_ATT:N-N (cell,H295r) MOD_ATT:N-N (deoxycytidine,aza) OBJ:V-N (with,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,7) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,deoxycytidine) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (expression,basal) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__)
+------------------------------COMP:V-N(In)-----------------------------+ | +---------------------SUBJ:V-N--------------------+ +MOD_ATT:N-+ | +-----------OBJ:V-N----------+ +-----OBJ:V-N----+----COMP:N-N(of)---+ | +MOD_A+ +-MOD_ATT:N-N+ | +MOD_ATT:+COMP:N+ | | +MOD_ATT:+ +MOD_ATT+ | | | | | | | | | | | | | | | In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases basal expression of __SP__ __NODE__ . MOD_ATT:N-N (cell,NCI) MOD_ATT:N-N (cell,H295r) MOD_ATT:N-N (deoxycytidine,aza) OBJ:V-N (with,day) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,7) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,deoxycytidine) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (expression,basal) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__)